Clinical trial

Breast Cancer & Antiestrogenic Therapy & Brain

NCT06346457

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2024-04-01

PhaseN/A

Study timeline

Study start (estimated)2024-04-01Date precision: day

Registry last updated2024-04-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancer Femaleunresolved

Healthy Femaleunresolved

Menopauseunresolved

Anti-estrogenic Therapyunresolved

Interventions

TamoxifenDRUG · verified · RxNorm: tamoxifen

LetrozoleDRUG · verified · RxNorm: letrozole

Letrozole + GnRHDRUG

Sponsors & collaborators

International Research Training Group 2804lead sponsor

German Research Foundationcollaborator

University Hospital Tuebingencollaborator

Uppsala Universitycollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06346457 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.